| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.775 | 0.005 | 0.889 | Cholesterol antagonist | 0.889 0.003 CID_154699628 | CID_154699628 | |
| 0.762 | 0.005 | 0.762 | Aldehyde oxidase inhibitor | |||
| 0.724 | 0.004 | 0.785 | Histamine release inhibitor | 0.785 0.004 CID_154699628 | CID_154699628 | |
| 0.728 | 0.02 | 0.728 | Caspase 9 stimulant | 0.701 0.024 CID_154699628 | ||
| 0.693 | 0.003 | 0.693 | Alcohol oxidase inhibitor | 0.064 0.033 CID_154699628 | ||
| 0.687 | 0.003 | 0.687 | Peroxidase inhibitor | |||
| 0.679 | 0.008 | 0.679 | Vasodilator, peripheral | 0.644 0.011 CID_154699628 | ||
| 0.663 | 0.004 | 0.663 | GABA C receptor rho-3 antagonist | |||
| 0.655 | 0.004 | 0.655 | Anesthetic general | 0.62 0.004 CID_154699628 | ||
| 0.613 | 0.009 | 0.631 | 5 Hydroxytryptamine release inhibitor | 0.631 0.008 CID_154699628 | CID_154699628 | |
| 0.588 | 0.014 | 0.658 | Spasmolytic | 0.658 0.008 CID_154699628 | CID_154699628 | |
| 0.567 | 0.003 | 0.567 | Succinate dehydrogenase inhibitor | 0.252 0.022 CID_154699628 | ||
| 0.57 | 0.009 | 0.798 | Vasodilator, coronary | 0.798 0.004 CID_154699628 | CID_154699628 | |
| 0.565 | 0.01 | 0.565 | Calcium channel L-type activator | 0.345 0.121 CID_154699628 | ||
| 0.544 | 0.004 | 0.544 | Anesthetic local | 0.103 0.08 CID_154699628 | ||
| 0.563 | 0.03 | 0.563 | 15-Lipoxygenase inhibitor | |||
| 0.541 | 0.01 | 0.541 | Superoxide dismutase inhibitor | |||
| 0.561 | 0.036 | 0.799 | Transcription factor NF kappa B inhibitor | 0.799 0.013 CID_154699628 | CID_154699628 | |
| 0.515 | 0.027 | 0.842 | Antithrombotic | 0.842 0.004 CID_154699628 | CID_154699628 | |
| 0.504 | 0.018 | 0.504 | Lipoxygenase inhibitor | |||
| 0.491 | 0.006 | 0.491 | Phospholipase C inhibitor | 0.381 0.012 CID_154699628 | ||
| 0.506 | 0.026 | 0.506 | 5 Hydroxytryptamine release stimulant | 0.429 0.04 CID_154699628 | ||
| 0.469 | 0.005 | 0.469 | Aldehyde dehydrogenase inhibitor | 0.364 0.007 CID_154699628 | ||
| 0.454 | 0.007 | 0.619 | Alpha-N-acetylglucosaminidase inhibitor | 0.619 0.004 CID_154699628 | CID_154699628 | |
| 0.452 | 0.011 | 0.452 | Calcium channel activator | 0.208 0.201 CID_154699628 | ||
| 0.438 | 0.003 | 0.438 | Toll-Like receptor 2 antagonist | 0.215 0.018 CID_154699628 | ||
| 0.435 | 0.003 | 0.435 | Keratolytic | 0.087 0.04 CID_154699628 | ||
| 0.437 | 0.009 | 0.437 | 5 Hydroxytryptamine uptake stimulant | 0.19 0.174 CID_154699628 | ||
| 0.427 | 0.01 | 0.672 | Monophenol monooxygenase inhibitor | 0.672 0.004 CID_154699628 | CID_154699628 | |
| 0.43 | 0.019 | 0.495 | Vasodilator | 0.495 0.012 CID_154699628 | CID_154699628 | |
| 0.415 | 0.004 | 0.728 | Cyclooxygenase 3 inhibitor | 0.728 0.001 CID_154699628 | CID_154699628 | |
| 0.416 | 0.007 | 0.416 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.419 | 0.014 | 0.562 | Cyclic AMP phosphodiesterase inhibitor | 0.562 0.005 CID_154699628 | CID_154699628 | |
| 0.401 | 0.004 | 0.401 | TRPA1 agonist | 0.182 0.015 CID_154699628 | ||
| 0.39 | 0.005 | 0.39 | Phospholipase A2 inhibitor | 0.314 0.011 CID_154699628 | ||
| 0.405 | 0.038 | 0.405 | 12-Lipoxygenase inhibitor | |||
| 0.362 | 0.003 | 0.362 | Creatine kinase inhibitor | 0.09 0.072 CID_154699628 | ||
| 0.366 | 0.012 | 0.366 | Lipocortins synthesis antagonist | 0.284 0.024 CID_154699628 | ||
| 0.371 | 0.017 | 0.599 | Non-steroidal antiinflammatory agent | 0.599 0.004 CID_154699628 | CID_154699628 | |
| 0.359 | 0.005 | 0.359 | Carbonic anhydrase XV inhibitor | |||
| 0.39 | 0.037 | 0.658 | Antioxidant | 0.658 0.008 CID_154699628 | CID_154699628 | |
| 0.407 | 0.053 | 0.407 | Thyroid hormone antagonist | |||
| 0.407 | 0.057 | 0.407 | Calpain 2 inhibitor | |||
| 0.353 | 0.005 | 0.655 | Mediator release inhibitor | 0.655 0.003 CID_154699628 | CID_154699628 | |
| 0.353 | 0.004 | 0.353 | Adenylate kinase inhibitor | 0.284 0.008 CID_154699628 | ||
| 0.352 | 0.004 | 0.352 | Macrophage migration inhibitory factor inhibitor | |||
| 0.358 | 0.011 | 0.498 | Protein kinase stimulant | 0.498 0.004 CID_154699628 | CID_154699628 | |
| 0.372 | 0.028 | 0.372 | Sodium/bile acid cotransporter inhibitor | 0.299 0.08 CID_154699628 | ||
| 0.377 | 0.033 | 0.59 | Free radical scavenger | 0.59 0.009 CID_154699628 | CID_154699628 | |
| 0.394 | 0.051 | 0.624 | Immunostimulant | 0.624 0.014 CID_154699628 | CID_154699628 | |
| 0.355 | 0.016 | 0.536 | Melanin inhibitor | 0.536 0.005 CID_154699628 | CID_154699628 | |
| 0.367 | 0.028 | 0.375 | Psychostimulant | 0.375 0.027 CID_154699628 | CID_154699628 | |
| 0.355 | 0.028 | 0.499 | Interleukin agonist | 0.499 0.009 CID_154699628 | CID_154699628 | |
| 0.341 | 0.014 | 0.669 | Amylase inhibitor | 0.669 0.003 CID_154699628 | CID_154699628 | |
| 0.329 | 0.004 | 0.447 | Photosensitizer | 0.447 0.003 CID_154699628 | CID_154699628 | |
| 0.375 | 0.061 | 0.375 | Thyroid hormone beta antagonist | |||
| 0.384 | 0.07 | 0.547 | Immunosuppressant | 0.547 0.021 CID_154699628 | CID_154699628 | |
| 0.312 | 0.003 | 0.312 | Ornithine decarboxylase inhibitor | 0.199 0.005 CID_154699628 | ||
| 0.327 | 0.018 | 0.327 | Gastrin inhibitor | 0.29 0.04 CID_154699628 | ||
| 0.31 | 0.005 | 0.31 | GABA C receptor rho-2 antagonist | |||
| 0.412 | 0.108 | 0.611 | Apoptosis agonist | 0.611 0.047 CID_154699628 | CID_154699628 | |
| 0.357 | 0.053 | 0.542 | Apoptosis antagonist | 0.542 0.015 CID_154699628 | CID_154699628 | |
| 0.413 | 0.109 | 0.655 | Alpha-glucosidase inhibitor | 0.655 0.042 CID_154699628 | CID_154699628 | |
| 0.305 | 0.005 | 0.305 | Carbonic anhydrase III inhibitor | 0.166 0.023 CID_154699628 | ||
| 0.337 | 0.041 | 0.695 | Hypoglycemic | 0.695 0.005 CID_154699628 | CID_154699628 | |
| 0.328 | 0.035 | 0.468 | DNA synthesis inhibitor | 0.468 0.016 CID_154699628 | CID_154699628 | |
| 0.309 | 0.021 | 0.309 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.219 0.059 CID_154699628 | ||
| 0.315 | 0.029 | 0.315 | RNA-directed DNA polymerase inhibitor | 0.254 0.047 CID_154699628 | ||
| 0.305 | 0.019 | 0.456 | Interferon gamma antagonist | 0.456 0.008 CID_154699628 | CID_154699628 | |
| 0.326 | 0.042 | 0.419 | Hypolipemic | 0.419 0.022 CID_154699628 | CID_154699628 | |
| 0.296 | 0.016 | 0.296 | Insulin sensitizer | 0.272 0.024 CID_154699628 | ||
| 0.324 | 0.045 | 0.324 | Insulysin inhibitor | |||
| 0.285 | 0.007 | 0.285 | Carbonic anhydrase VI inhibitor | 0.116 0.031 CID_154699628 | ||
| 0.369 | 0.091 | 0.658 | Antibacterial | 0.658 0.012 CID_154699628 | CID_154699628 | |
| 0.319 | 0.042 | 0.784 | Angiogenesis stimulant | 0.784 0.004 CID_154699628 | CID_154699628 | |
| 0.309 | 0.037 | 0.309 | Sigma receptor agonist | |||
| 0.389 | 0.12 | 0.389 | DNA directed DNA polymerase inhibitor | |||
| 0.275 | 0.009 | 0.346 | Xanthine oxidase inhibitor | 0.346 0.005 CID_154699628 | CID_154699628 | |
| 0.348 | 0.083 | 0.348 | Prostaglandin dehydrogenase inhibitor | |||
| 0.267 | 0.008 | 0.267 | Carbonic anhydrase XIII inhibitor | 0.245 0.009 CID_154699628 | ||
| 0.279 | 0.022 | 0.377 | Lipid peroxidase inhibitor | 0.377 0.011 CID_154699628 | CID_154699628 | |
| 0.269 | 0.015 | 0.269 | Cholesterol synthesis inhibitor | 0.179 0.032 CID_154699628 | ||
| 0.259 | 0.007 | 0.259 | Alcohol dehydrogenase inhibitor | 0.169 0.016 CID_154699628 | ||
| 0.258 | 0.006 | 0.258 | GABA C receptor antagonist | |||
| 0.275 | 0.026 | 0.293 | Neurotrophic factor enhancer | 0.293 0.02 CID_154699628 | CID_154699628 | |
| 0.249 | 0.006 | 0.249 | Arachidonic acid antagonist | 0.206 0.028 CID_154699628 | ||
| 0.251 | 0.009 | 0.251 | Catalase inhibitor | |||
| 0.253 | 0.011 | 0.253 | Farnesoid X receptor antagonist | 0.13 0.083 CID_154699628 | ||
| 0.251 | 0.013 | 0.425 | UDP-glucose 4-epimerase inhibitor | 0.425 0.005 CID_154699628 | CID_154699628 | |
| 0.296 | 0.058 | 0.331 | DNA damaging | 0.331 0.047 CID_154699628 | CID_154699628 | |
| 0.247 | 0.014 | 0.247 | Interleukin 4 antagonist | 0.192 0.025 CID_154699628 | ||
| 0.248 | 0.015 | 0.248 | Cystathionine beta-synthase inhibitor | 0.193 0.026 CID_154699628 | ||
| 0.271 | 0.038 | 0.337 | DNA methyltransferase I inhibitor | 0.337 0.016 CID_154699628 | CID_154699628 | |
| 0.238 | 0.008 | 0.238 | CF transmembrane conductance regulator agonist | 0.183 0.034 CID_154699628 | ||
| 0.253 | 0.024 | 0.253 | Acetylcholine M1 receptor antagonist | |||
| 0.25 | 0.022 | 0.25 | Nav1.2 sodium channel blocker | |||
| 0.228 | 0.005 | 0.228 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.23 | 0.007 | 0.23 | Vanilloid 1 agonist | 0.208 0.01 CID_154699628 | ||
| 0.233 | 0.01 | 0.233 | Calcium antagonist | |||
| 0.23 | 0.009 | 0.23 | Porphobilinogen synthase inhibitor | |||
| 0.23 | 0.01 | 0.23 | Histidine decarboxylase inhibitor | |||
| 0.224 | 0.005 | 0.224 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.226 | 0.01 | 0.226 | Estrogen antagonist | 0.106 0.084 CID_154699628 | ||
| 0.235 | 0.019 | 0.235 | DNA polymerase I inhibitor | 0.219 0.023 CID_154699628 | ||
| 0.276 | 0.061 | 0.423 | Platelet antagonist | 0.423 0.023 CID_154699628 | CID_154699628 | |
| 0.233 | 0.019 | 0.233 | 5-Lipoxygenase inhibitor | |||
| 0.248 | 0.034 | 0.248 | Amyloid beta precursor protein antagonist | |||
| 0.216 | 0.006 | 0.216 | GABA C receptor rho-1 antagonist | |||
| 0.219 | 0.009 | 0.395 | Triose-phosphate isomerase inhibitor | 0.395 0.003 CID_154699628 | CID_154699628 | |
| 0.263 | 0.054 | 0.263 | Amyloid beta aggregation inhibitor | 0.182 0.088 CID_154699628 | ||
| 0.226 | 0.018 | 0.226 | Neurotrophic factor | 0.177 0.039 CID_154699628 | ||
| 0.237 | 0.034 | 0.237 | Protein-tyrosine phosphatase inhibitor | 0.189 0.051 CID_154699628 | ||
| 0.204 | 0.003 | 0.204 | Ca2+-transporting ATPase inhibitor | 0.193 0.004 CID_154699628 | ||
| 0.285 | 0.085 | 0.444 | Interleukin 2 agonist | 0.444 0.017 CID_154699628 | CID_154699628 | |
| 0.242 | 0.043 | 0.242 | Dual specificity phosphatase 3 inhibitor | |||
| 0.217 | 0.019 | 0.217 | Ferrochelatase inhibitor | |||
| 0.242 | 0.046 | 0.505 | Hepatoprotectant | 0.505 0.007 CID_154699628 | CID_154699628 | |
| 0.212 | 0.016 | 0.212 | Nav1.6 sodium channel blocker | |||
| 0.203 | 0.008 | 0.203 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.197 | 0.003 | 0.197 | GABA B receptor agonist | |||
| 0.197 | 0.007 | 0.197 | Glutamate decarboxylase inhibitor | |||
| 0.197 | 0.007 | 0.197 | Heat shock protein 70 antagonist | 0.192 0.008 CID_154699628 | ||
| 0.211 | 0.021 | 0.211 | Nav1.3 sodium channel blocker | |||
| 0.212 | 0.022 | 0.212 | Chelator | |||
| 0.233 | 0.047 | 0.233 | P-glycoprotein inhibitor | 0.218 0.054 CID_154699628 | ||
| 0.191 | 0.008 | 0.191 | DOPA decarboxylase inhibitor | |||
| 0.189 | 0.006 | 0.189 | Glutathione S-transferase inhibitor | 0.104 0.034 CID_154699628 | ||
| 0.211 | 0.029 | 0.351 | ATPase inhibitor | 0.351 0.004 CID_154699628 | CID_154699628 | |
| 0.188 | 0.008 | 0.207 | Toll-Like receptor 4 antagonist | 0.207 0.005 CID_154699628 | CID_154699628 | |
| 0.181 | 0.004 | 0.181 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.234 | 0.057 | 0.333 | DNA methylase inhibitor | 0.333 0.02 CID_154699628 | CID_154699628 | |
| 0.186 | 0.011 | 0.186 | Prolactin inhibitor | |||
| 0.185 | 0.011 | 0.185 | Estrogen receptor beta antagonist | |||
| 0.253 | 0.08 | 0.253 | Transcription factor STAT3 inhibitor | |||
| 0.175 | 0.003 | 0.175 | Squalene epoxidase inhibitor | 0.091 0.007 CID_154699628 | ||
| 0.182 | 0.011 | 0.182 | Electrolyte absorption antagonist | |||
| 0.179 | 0.007 | 0.179 | Anabolic | 0.125 0.035 CID_154699628 | ||
| 0.218 | 0.047 | 0.218 | Dual specificity phosphatase inhibitor | |||
| 0.201 | 0.031 | 0.201 | Catenin beta inhibitor | |||
| 0.205 | 0.034 | 0.205 | Bone formation stimulant | 0.154 0.056 CID_154699628 | ||
| 0.192 | 0.023 | 0.192 | Aminopeptidase B inhibitor | |||
| 0.201 | 0.034 | 0.201 | Neurotensin receptor agonist | |||
| 0.176 | 0.01 | 0.176 | Adrenaline agonist | |||
| 0.186 | 0.021 | 0.186 | Adenylate cyclase stimulant | 0.137 0.087 CID_154699628 | ||
| 0.182 | 0.018 | 0.182 | Mucolytic | 0.172 0.022 CID_154699628 | ||
| 0.168 | 0.004 | 0.168 | Nicotinic acid receptor agonist | |||
| 0.187 | 0.025 | 0.187 | Antibacterial (Helicobacter pylori) | 0.113 0.092 CID_154699628 | ||
| 0.238 | 0.076 | 0.34 | Antiamyloidogenic | 0.34 0.041 CID_154699628 | CID_154699628 | |
| 0.341 | 0.18 | 0.77 | Antiinflammatory | 0.77 0.019 CID_154699628 | CID_154699628 | |
| 0.175 | 0.014 | 0.273 | Phosphofructokinase-1 inhibitor | 0.273 0.006 CID_154699628 | CID_154699628 | |
| 0.164 | 0.003 | 0.164 | Glutamate (mGluR6) antagonist | 0.091 0.015 CID_154699628 | ||
| 0.194 | 0.034 | 0.204 | Mannose-6-phosphate isomerase inhibitor | 0.204 0.028 CID_154699628 | CID_154699628 | |
| 0.237 | 0.078 | 0.237 | Calpain inhibitor | |||
| 0.174 | 0.016 | 0.181 | Sphingomyelinase inhibitor | 0.181 0.014 CID_154699628 | CID_154699628 | |
| 0.162 | 0.004 | 0.162 | Estrogen-related receptor beta agonist | |||
| 0.182 | 0.025 | 0.457 | Expectorant | 0.457 0.004 CID_154699628 | CID_154699628 | |
| 0.189 | 0.032 | 0.189 | Protein-tyrosine phosphatase 1B inhibitor | 0.18 0.035 CID_154699628 | ||
| 0.219 | 0.062 | 0.449 | Platelet adhesion inhibitor | 0.449 0.008 CID_154699628 | CID_154699628 | |
| 0.254 | 0.097 | 0.279 | Hypoxia-inducible factor 1 alpha inhibitor | 0.279 0.077 CID_154699628 | CID_154699628 | |
| 0.164 | 0.008 | 0.164 | Acyl-CoA dehydrogenase inhibitor | 0.079 0.022 CID_154699628 | ||
| 0.16 | 0.004 | 0.16 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.164 | 0.008 | 0.164 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.231 | 0.076 | 0.231 | Neuropeptide Y2 antagonist | |||
| 0.259 | 0.104 | 0.309 | Caspase 3 stimulant | 0.309 0.075 CID_154699628 | CID_154699628 | |
| 0.162 | 0.008 | 0.164 | Glutamate release inhibitor | 0.164 0.007 CID_154699628 | CID_154699628 | |
| 0.202 | 0.047 | 0.202 | Cytidine deaminase inhibitor | |||
| 0.218 | 0.063 | 0.231 | Nitric-oxide synthase stimulant | 0.231 0.048 CID_154699628 | CID_154699628 | |
| 0.164 | 0.01 | 0.164 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.158 | 0.007 | 0.158 | GABA aminotransferase inhibitor | 0.124 0.015 CID_154699628 | ||
| 0.198 | 0.05 | 0.198 | Antipruritic | |||
| 0.187 | 0.039 | 0.187 | NADPH oxidase inhibitor | 0.134 0.067 CID_154699628 | ||
| 0.209 | 0.064 | 0.438 | Nitric oxide antagonist | 0.438 0.021 CID_154699628 | CID_154699628 | |
| 0.305 | 0.163 | 0.305 | DNA polymerase beta inhibitor | |||
| 0.17 | 0.027 | 0.17 | GABA C receptor agonist | |||
| 0.148 | 0.005 | 0.148 | Purinergic P2Y antagonist | 0.104 0.009 CID_154699628 | ||
| 0.152 | 0.01 | 0.152 | Leukotriene antagonist | 0.119 0.015 CID_154699628 | ||
| 0.175 | 0.035 | 0.339 | Alkylator | 0.339 0.01 CID_154699628 | CID_154699628 | |
| 0.156 | 0.017 | 0.156 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.155 | 0.016 | 0.28 | NADH dehydrogenase inhibitor | 0.28 0.007 CID_154699628 | CID_154699628 | |
| 0.179 | 0.04 | 0.338 | Cell wall synthesis inhibitor | 0.338 0.008 CID_154699628 | CID_154699628 | |
| 0.146 | 0.008 | 0.146 | Bile acid receptor antagonist | 0.1 0.048 CID_154699628 | ||
| 0.148 | 0.01 | 0.243 | Interferon agonist | 0.243 0.004 CID_154699628 | CID_154699628 | |
| 0.142 | 0.005 | 0.234 | Carbonic anhydrase XIV inhibitor | 0.234 0.004 CID_154699628 | CID_154699628 | |
| 0.162 | 0.029 | 0.162 | Nav1.1 sodium channel blocker | |||
| 0.174 | 0.041 | 0.174 | Toll-Like receptor antagonist | |||
| 0.164 | 0.031 | 0.202 | Microtubule formation inhibitor | 0.202 0.019 CID_154699628 | CID_154699628 | |
| 0.143 | 0.01 | 0.143 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.156 | 0.024 | 0.156 | Caspase 3 inhibitor | |||
| 0.14 | 0.008 | 0.14 | Xanthine dehydrogenase inhibitor | 0.049 0.047 CID_154699628 | ||
| 0.154 | 0.025 | 0.192 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.192 0.017 CID_154699628 | CID_154699628 | |
| 0.142 | 0.013 | 0.142 | Interleukin 5 antagonist | 0.123 0.022 CID_154699628 | ||
| 0.135 | 0.007 | 0.135 | Beta adrenoreceptor antagonist | |||
| 0.141 | 0.013 | 0.141 | Estrogen receptor alpha antagonist | |||
| 0.136 | 0.009 | 0.159 | Neuraminidase (influenza) inhibitor | 0.159 0.007 CID_154699628 | CID_154699628 | |
| 0.156 | 0.028 | 0.156 | Protein kinase C gamma inhibitor | |||
| 0.163 | 0.037 | 0.163 | Acetylcholine muscarinic antagonist | |||
| 0.176 | 0.05 | 0.176 | Thiol protease inhibitor | |||
| 0.138 | 0.013 | 0.138 | Argininosuccinate synthase inhibitor | 0.08 0.025 CID_154699628 | ||
| 0.134 | 0.009 | 0.134 | Glycine receptor agonist | 0.105 0.018 CID_154699628 | ||
| 0.236 | 0.112 | 0.236 | Streptokinase A inhibitor | |||
| 0.127 | 0.004 | 0.377 | Alpha-mannosidase inhibitor | 0.377 0.002 CID_154699628 | CID_154699628 | |
| 0.143 | 0.021 | 0.157 | Acetylcholine release stimulant | 0.157 0.013 CID_154699628 | CID_154699628 | |
| 0.167 | 0.046 | 0.167 | Calcium channel blocker | |||
| 0.126 | 0.007 | 0.17 | Leukotriene B4 antagonist | 0.17 0.004 CID_154699628 | CID_154699628 | |
| 0.14 | 0.022 | 0.14 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.128 | 0.011 | 0.128 | Carbonic anhydrase VB inhibitor | |||
| 0.148 | 0.032 | 0.148 | Bronchodilator | |||
| 0.126 | 0.01 | 0.126 | CDC25B inhibitor | |||
| 0.128 | 0.014 | 0.128 | Calcium channel L-type blocker | |||
| 0.143 | 0.03 | 0.143 | Gastric antisecretory | |||
| 0.205 | 0.092 | 0.399 | Peptidyltransferase inhibitor | 0.399 0.007 CID_154699628 | CID_154699628 | |
| 0.118 | 0.006 | 0.118 | Aconitate hydratase inhibitor | |||
| 0.122 | 0.009 | 0.135 | Neuraminidase inhibitor | 0.135 0.008 CID_154699628 | CID_154699628 | |
| 0.126 | 0.013 | 0.126 | Estrogen agonist | 0.073 0.025 CID_154699628 | ||
| 0.177 | 0.065 | 0.177 | Heat shock protein 90 alpha antagonist | |||
| 0.135 | 0.024 | 0.135 | Cathepsin G inhibitor | |||
| 0.115 | 0.004 | 0.115 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.131 | 0.02 | 0.131 | Glutamate dehydrogenase inhibitor | 0.08 0.045 CID_154699628 | ||
| 0.195 | 0.084 | 0.195 | Platelet aggregation inhibitor | 0.163 0.113 CID_154699628 | ||
| 0.169 | 0.059 | 0.308 | Hexokinase inhibitor | 0.308 0.01 CID_154699628 | CID_154699628 | |
| 0.196 | 0.086 | 0.196 | Interleukin antagonist | |||
| 0.127 | 0.017 | 0.127 | CDC25A inhibitor | |||
| 0.17 | 0.061 | 0.328 | Diuretic | 0.328 0.019 CID_154699628 | CID_154699628 | |
| 0.116 | 0.008 | 0.171 | Interferon inducer | 0.171 0.004 CID_154699628 | CID_154699628 | |
| 0.174 | 0.066 | 0.366 | Thrombolytic | 0.366 0.015 CID_154699628 | CID_154699628 | |
| 0.113 | 0.005 | 0.363 | Mannosidase inhibitor | 0.363 0.002 CID_154699628 | CID_154699628 | |
| 0.151 | 0.044 | 0.151 | Adenylate cyclase inhibitor | |||
| 0.119 | 0.013 | 0.119 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.118 | 0.012 | 0.118 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.092 0.019 CID_154699628 | ||
| 0.158 | 0.053 | 0.158 | Neuropeptide Y1 antagonist | |||
| 0.115 | 0.011 | 0.115 | Beta 3 adrenoreceptor antagonist | |||
| 0.127 | 0.023 | 0.141 | Interleukin 12 antagonist | 0.141 0.015 CID_154699628 | CID_154699628 | |
| 0.154 | 0.05 | 0.154 | Cholinergic antagonist | |||
| 0.108 | 0.004 | 0.108 | Lysophosphatidic acid 3 receptor antagonist | 0.054 0.03 CID_154699628 | ||
| 0.136 | 0.033 | 0.346 | Beta glucuronidase inhibitor | 0.346 0.005 CID_154699628 | CID_154699628 | |
| 0.134 | 0.031 | 0.134 | Electron transport complex I inhibitor | |||
| 0.115 | 0.013 | 0.115 | Purinergic P2X1 antagonist | |||
| 0.163 | 0.061 | 0.319 | NOS3 expression enhancer | 0.319 0.015 CID_154699628 | CID_154699628 | |
| 0.108 | 0.007 | 0.108 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.107 | 0.006 | 0.107 | Sphingosine kinase inhibitor | |||
| 0.106 | 0.006 | 0.106 | Sphingosine kinase 2 inhibitor | |||
| 0.147 | 0.048 | 0.147 | Cathepsin H inhibitor | |||
| 0.158 | 0.059 | 0.47 | Hemostatic | 0.47 0.005 CID_154699628 | CID_154699628 | |
| 0.107 | 0.009 | 0.107 | Beta 1 adrenoreceptor antagonist | |||
| 0.121 | 0.024 | 0.189 | Phosphodiesterase 6D inhibitor | 0.189 0.005 CID_154699628 | CID_154699628 | |
| 0.209 | 0.111 | 0.209 | Cardiotonic | |||
| 0.104 | 0.008 | 0.104 | Potassium channel Kv1.3 blocker | |||
| 0.148 | 0.051 | 0.148 | Acetylcholine antagonist | |||
| 0.115 | 0.019 | 0.115 | Leukotriene synthesis inhibitor | |||
| 0.113 | 0.017 | 0.113 | D-Ala-D-Ala ligase inhibitor | |||
| 0.123 | 0.028 | 0.123 | ABCA1 expression enhancer | |||
| 0.12 | 0.025 | 0.197 | Transcription factor NF kappa B stimulant | 0.197 0.009 CID_154699628 | CID_154699628 | |
| 0.214 | 0.119 | 0.214 | Transcription factor STAT inhibitor | |||
| 0.11 | 0.016 | 0.11 | Biliverdin reductase inhibitor | 0.062 0.038 CID_154699628 | ||
| 0.108 | 0.014 | 0.108 | Toll-Like receptor 2 agonist | 0.091 0.015 CID_154699628 | ||
| 0.122 | 0.03 | 0.149 | Thioredoxin inhibitor | 0.149 0.017 CID_154699628 | CID_154699628 | |
| 0.096 | 0.004 | 0.096 | Glutamate (mGluR3) antagonist | |||
| 0.131 | 0.041 | 0.364 | AMP-activated protein kinase stimulant | 0.364 0.004 CID_154699628 | CID_154699628 | |
| 0.095 | 0.005 | 0.095 | Leukotriene C antagonist | 0.057 0.037 CID_154699628 | ||
| 0.097 | 0.01 | 0.102 | Nitric oxide donor | 0.102 0.008 CID_154699628 | CID_154699628 | |
| 0.096 | 0.009 | 0.096 | Oleamide hydrolase inhibitor | |||
| 0.11 | 0.024 | 0.11 | Vanilloid agonist | 0.081 0.068 CID_154699628 | ||
| 0.094 | 0.008 | 0.094 | Beta 2 adrenoreceptor antagonist | |||
| 0.109 | 0.024 | 0.109 | Aminopeptidase I inhibitor | |||
| 0.133 | 0.047 | 0.133 | Interleukin 8 antagonist | |||
| 0.132 | 0.047 | 0.132 | GABA receptor agonist | |||
| 0.108 | 0.025 | 0.108 | Carbonic anhydrase V inhibitor | |||
| 0.099 | 0.016 | 0.099 | Ornithine carbamoyltransferase inhibitor | 0.061 0.031 CID_154699628 | ||
| 0.14 | 0.057 | 0.14 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.108 | 0.026 | 0.155 | Glycine receptor antagonist | 0.155 0.006 CID_154699628 | CID_154699628 | |
| 0.163 | 0.082 | 0.163 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.087 | 0.005 | 0.087 | Dihydropteroate synthase inhibitor | |||
| 0.085 | 0.005 | 0.085 | Cholesterol esterase inhibitor | 0.048 0.032 CID_154699628 | ||
| 0.087 | 0.008 | 0.087 | Adenosine deaminase inhibitor | 0.083 0.009 CID_154699628 | ||
| 0.085 | 0.007 | 0.085 | Retinoid X receptor agonist | |||
| 0.175 | 0.096 | 0.175 | Pyruvate kinase inhibitor | |||
| 0.088 | 0.009 | 0.088 | Thromboxane synthase inhibitor | |||
| 0.179 | 0.101 | 0.179 | Histone acetyltransferase inhibitor | |||
| 0.113 | 0.035 | 0.113 | Histamine N-methyltransferase inhibitor | |||
| 0.085 | 0.007 | 0.086 | Adenine nucleotide translocase inhibitor | 0.086 0.007 CID_154699628 | CID_154699628 | |
| 0.142 | 0.065 | 0.142 | Alkaline phosphatase inhibitor | 0.141 0.066 CID_154699628 | ||
| 0.088 | 0.012 | 0.088 | Glucosylceramidase inhibitor | 0.082 0.014 CID_154699628 | ||
| 0.095 | 0.018 | 0.095 | MAP kinase kinase 7 inhibitor | |||
| 0.103 | 0.026 | 0.103 | Peroxisome proliferator-activated receptor gamma agonist | 0.073 0.046 CID_154699628 | ||
| 0.087 | 0.011 | 0.087 | Leukocyte elastase inhibitor | |||
| 0.084 | 0.008 | 0.084 | Dihydroorotase inhibitor | |||
| 0.094 | 0.019 | 0.094 | Maillard reaction inhibitor | 0.049 0.044 CID_154699628 | ||
| 0.089 | 0.015 | 0.089 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.089 | 0.015 | 0.089 | Thromboxane antagonist | |||
| 0.093 | 0.02 | 0.093 | Acetylcholine M3 receptor antagonist | |||
| 0.091 | 0.019 | 0.091 | Androgen agonist | |||
| 0.081 | 0.009 | 0.081 | Beta 2 adrenoreceptor agonist | |||
| 0.092 | 0.02 | 0.092 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.08 | 0.009 | 0.121 | Glucose-6-phosphate isomerase inhibitor | 0.121 0.003 CID_154699628 | CID_154699628 | |
| 0.113 | 0.042 | 0.139 | Uric acid excretion stimulant | 0.139 0.027 CID_154699628 | CID_154699628 | |
| 0.2 | 0.131 | 0.2 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.086 | 0.018 | 0.086 | Transcription factor AP-1 inhibitor | 0.081 0.021 CID_154699628 | ||
| 0.082 | 0.014 | 0.082 | Estrogen receptor beta agonist | |||
| 0.072 | 0.005 | 0.072 | Beta adrenoreceptor agonist | |||
| 0.074 | 0.007 | 0.074 | Prostaglandin agonist | |||
| 0.076 | 0.009 | 0.076 | Pregnane X receptor antagonist | |||
| 0.074 | 0.008 | 0.074 | Glutamate (mGluR group III) antagonist | |||
| 0.152 | 0.086 | 0.245 | Interleukin 6 antagonist | 0.245 0.024 CID_154699628 | CID_154699628 | |
| 0.091 | 0.026 | 0.091 | Elastase 1 inhibitor | |||
| 0.095 | 0.03 | 0.095 | Lipase inhibitor | 0.07 0.054 CID_154699628 | ||
| 0.082 | 0.017 | 0.082 | Fatty acid synthase inhibitor | |||
| 0.073 | 0.008 | 0.073 | GABA B receptor antagonist | |||
| 0.08 | 0.015 | 0.08 | Thromboxane A2 antagonist | |||
| 0.068 | 0.005 | 0.068 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.07 | 0.008 | 0.07 | Dopamine D5 agonist | |||
| 0.097 | 0.035 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.123 0.015 CID_154699628 | CID_154699628 | |
| 0.065 | 0.005 | 0.065 | Leukotriene C4 antagonist | |||
| 0.073 | 0.013 | 0.073 | Estrogen receptor alpha agonist | |||
| 0.09 | 0.03 | 0.09 | Carbonic anhydrase VA inhibitor | |||
| 0.086 | 0.026 | 0.086 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.075 | 0.015 | 0.075 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.176 | 0.116 | 0.176 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.074 | 0.015 | 0.074 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.064 | 0.005 | 0.064 | Retinoid X receptor antagonist | |||
| 0.062 | 0.004 | 0.062 | Glutamate (mGluR3) agonist | |||
| 0.076 | 0.018 | 0.076 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.074 | 0.016 | 0.074 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.09 | 0.032 | 0.403 | Selectin antagonist | 0.403 0.003 CID_154699628 | CID_154699628 | |
| 0.128 | 0.071 | 0.128 | M17 leucyl aminopeptidase inhibitor | |||
| 0.088 | 0.032 | 0.088 | Amidase inhibitor | |||
| 0.065 | 0.01 | 0.065 | Retinoid X alpha receptor agonist | |||
| 0.061 | 0.005 | 0.061 | Angiotensin AT1 receptor antagonist | |||
| 0.088 | 0.034 | 0.088 | Adenosine A3 receptor antagonist | |||
| 0.096 | 0.042 | 0.096 | Acetylcholine nicotinic antagonist | |||
| 0.062 | 0.009 | 0.062 | GABA uptake inhibitor | |||
| 0.076 | 0.023 | 0.076 | Phosphodiesterase 1C inhibitor | |||
| 0.072 | 0.021 | 0.072 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.065 | 0.013 | 0.065 | Glutamate (mGluR1a) antagonist | |||
| 0.057 | 0.006 | 0.057 | Liver X receptor beta antagonist | |||
| 0.111 | 0.06 | 0.111 | Falcipain 3 inhibitor | |||
| 0.056 | 0.005 | 0.056 | Prostaglandin EP2 agonist | 0.024 0.015 CID_154699628 | ||
| 0.057 | 0.006 | 0.074 | Uridine phosphorylase inhibitor | 0.074 0.004 CID_154699628 | CID_154699628 | |
| 0.062 | 0.011 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.071 0.007 CID_154699628 | CID_154699628 | |
| 0.056 | 0.005 | 0.056 | Angiotensin II receptor antagonist | |||
| 0.08 | 0.029 | 0.08 | Acetylcholine M2 receptor antagonist | |||
| 0.06 | 0.009 | 0.06 | Retinoic acid alpha receptor agonist | 0.036 0.034 CID_154699628 | ||
| 0.067 | 0.016 | 0.067 | Carbonic anhydrase VII inhibitor | |||
| 0.069 | 0.019 | 0.069 | Plasminogen activator inhibitor antagonist | |||
| 0.13 | 0.08 | 0.13 | Cytokine production inhibitor | |||
| 0.067 | 0.017 | 0.067 | CD45 antagonist | |||
| 0.065 | 0.015 | 0.065 | NMDA receptor subunit 3A antagonist | |||
| 0.08 | 0.03 | 0.08 | Protein kinase C beta inhibitor | |||
| 0.102 | 0.053 | 0.102 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.064 | 0.015 | 0.064 | 5-Alpha-reductase inhibitor | |||
| 0.072 | 0.023 | 0.072 | NMDA 2A receptor antagonist | |||
| 0.06 | 0.011 | 0.06 | Nicotinic acid receptor 2 agonist | |||
| 0.053 | 0.005 | 0.053 | Retinoid X alpha receptor antagonist | |||
| 0.138 | 0.09 | 0.138 | MAP kinase kinase 4 inhibitor | |||
| 0.097 | 0.049 | 0.097 | NMDA receptor antagonist | |||
| 0.052 | 0.005 | 0.052 | Estrogen-related receptor beta antagonist | |||
| 0.136 | 0.089 | 0.136 | Heat shock protein 90 antagonist | |||
| 0.054 | 0.007 | 0.054 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.073 | 0.028 | 0.073 | Acetylcholine M5 receptor antagonist | |||
| 0.063 | 0.018 | 0.235 | Heparanase inhibitor | 0.235 0.002 CID_154699628 | CID_154699628 | |
| 0.086 | 0.041 | 0.086 | Acetylcholine M4 receptor antagonist | |||
| 0.049 | 0.004 | 0.049 | Calcium-independent phospholipase A2 inhibitor | 0.036 0.018 CID_154699628 | ||
| 0.049 | 0.005 | 0.049 | Retinoic acid receptor agonist | 0.024 0.014 CID_154699628 | ||
| 0.082 | 0.038 | 0.097 | Phosphodiesterase VI inhibitor | 0.097 0.022 CID_154699628 | CID_154699628 | |
| 0.072 | 0.028 | 0.072 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.057 | 0.014 | 0.057 | Liver X receptor alpha agonist | |||
| 0.047 | 0.004 | 0.047 | Estrogen-related receptor gamma antagonist | |||
| 0.073 | 0.03 | 0.073 | Ribonucleotide reductase inhibitor | |||
| 0.065 | 0.023 | 0.065 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.05 | 0.008 | 0.05 | ATP citrate lysase inhibitor | |||
| 0.046 | 0.005 | 0.046 | Glutamate (mGluR1) agonist | |||
| 0.07 | 0.029 | 0.07 | Protein kinase C eta inhibitor | |||
| 0.075 | 0.034 | 0.075 | Glutamate (mGluR7) antagonist | |||
| 0.053 | 0.013 | 0.053 | Sphingosine kinase 1 inhibitor | |||
| 0.075 | 0.036 | 0.075 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.133 | 0.094 | 0.302 | Insulin secretagoues | 0.302 0.012 CID_154699628 | CID_154699628 | |
| 0.092 | 0.053 | 0.092 | Androgen antagonist | |||
| 0.111 | 0.072 | 0.111 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.047 | 0.008 | 0.047 | Leukotriene B4 receptor 1 antagonist | 0.037 0.014 CID_154699628 | ||
| 0.055 | 0.016 | 0.058 | Guanylate cyclase inhibitor | 0.058 0.013 CID_154699628 | CID_154699628 | |
| 0.052 | 0.014 | 0.052 | Farnesoid X receptor agonist | |||
| 0.071 | 0.032 | 0.074 | Prostaglandin EP2 antagonist | 0.074 0.03 CID_154699628 | CID_154699628 | |
| 0.111 | 0.073 | 0.111 | Proteasome inhibitor | |||
| 0.045 | 0.008 | 0.045 | Purinergic P2Y12 antagonist | 0.032 0.011 CID_154699628 | ||
| 0.065 | 0.027 | 0.076 | Lipocortins synthesis agonist | 0.076 0.016 CID_154699628 | CID_154699628 | |
| 0.042 | 0.005 | 0.042 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.056 | 0.018 | 0.093 | Cytokine production stimulant | 0.093 0.004 CID_154699628 | CID_154699628 | |
| 0.048 | 0.01 | 0.048 | Free fatty acid receptor 1 antagonist | |||
| 0.04 | 0.003 | 0.04 | Neuraminidase (Influenza B) inhibitor | 0.023 0.01 CID_154699628 | ||
| 0.096 | 0.059 | 0.096 | Potassium channel (Ca-activated) activator | |||
| 0.042 | 0.005 | 0.042 | Prostaglandin F2 alpha agonist | 0.021 0.019 CID_154699628 | ||
| 0.06 | 0.023 | 0.06 | Vanilloid 2 antagonist | |||
| 0.064 | 0.027 | 0.064 | Acetyl-CoA transferase inhibitor | |||
| 0.04 | 0.004 | 0.065 | Vanilloid 2 agonist | 0.065 0.002 CID_154699628 | CID_154699628 | |
| 0.085 | 0.05 | 0.085 | Caspase 7 inhibitor | |||
| 0.088 | 0.052 | 0.088 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.101 | 0.066 | 0.101 | Urease inhibitor | |||
| 0.064 | 0.029 | 0.064 | Ryanodine receptor antagonist | |||
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR4) antagonist | |||
| 0.078 | 0.044 | 0.078 | Epoxide hydrolase inhibitor | |||
| 0.055 | 0.021 | 0.055 | NMDA receptor subunit 3B antagonist | |||
| 0.054 | 0.021 | 0.054 | Oxytocin agonist | |||
| 0.048 | 0.016 | 0.048 | Kainate receptor agonist | |||
| 0.038 | 0.006 | 0.038 | Nicotinic acid receptor 2 antagonist | |||
| 0.046 | 0.014 | 0.046 | RNA-directed RNA polymerase inhibitor | |||
| 0.036 | 0.005 | 0.036 | Retinoic acid beta receptor agonist | |||
| 0.044 | 0.012 | 0.051 | Ceramide glucosyltransferase inhibitor | 0.051 0.006 CID_154699628 | CID_154699628 | |
| 0.067 | 0.036 | 0.067 | Calcium channel P-type blocker | |||
| 0.086 | 0.055 | 0.086 | mTOR complex 2 inhibitor | |||
| 0.142 | 0.111 | 0.142 | Tumour necrosis factor antagonist | |||
| 0.045 | 0.015 | 0.045 | Glutamate (mGluR8) agonist | |||
| 0.043 | 0.014 | 0.043 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.13 | 0.101 | 0.13 | Pregnane X receptor agonist | |||
| 0.037 | 0.008 | 0.037 | Prostaglandin E2 agonist | |||
| 0.042 | 0.014 | 0.042 | Carnitine palmitoyltransferase inhibitor | |||
| 0.032 | 0.004 | 0.032 | Carbonic anhydrase X inhibitor | |||
| 0.032 | 0.004 | 0.032 | Carbonic anhydrase VIII inhibitor | |||
| 0.07 | 0.041 | 0.07 | Potassium channel (ATP-sensitive) blocker | |||
| 0.05 | 0.023 | 0.05 | Geranyltranstransferase inhibitor | |||
| 0.091 | 0.064 | 0.091 | Protein kinase C zeta inhibitor | |||
| 0.051 | 0.024 | 0.051 | Benzodiazepine antagonist | |||
| 0.119 | 0.092 | 0.119 | Histone deacetylase SIRT1 inhibitor | |||
| 0.066 | 0.04 | 0.066 | NMDA receptor glycine site agonist | |||
| 0.041 | 0.015 | 0.041 | Liver X receptor beta agonist | |||
| 0.04 | 0.014 | 0.04 | Melatonin receptor 1A agonist | |||
| 0.072 | 0.046 | 0.072 | Prostaglandin-E synthase inhibitor | |||
| 0.065 | 0.039 | 0.065 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.029 | 0.004 | 0.029 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.03 | 0.005 | 0.078 | Ileal bile acid transport inhibitor | 0.078 0.002 CID_154699628 | CID_154699628 | |
| 0.036 | 0.012 | 0.036 | Elastase 2B inhibitor | |||
| 0.036 | 0.012 | 0.036 | Elastase 3A inhibitor | |||
| 0.036 | 0.012 | 0.036 | Elastase 3B inhibitor | |||
| 0.031 | 0.006 | 0.031 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.058 | 0.033 | 0.058 | Dihydroorotate oxidase inhibitor | |||
| 0.066 | 0.042 | 0.066 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.029 | 0.004 | 0.029 | Estrogen-related receptor gamma agonist | |||
| 0.039 | 0.015 | 0.039 | HCV NS5B polymerase inhibitor | |||
| 0.227 | 0.204 | 0.227 | Transcription factor inhibitor | |||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | |||
| 0.031 | 0.008 | 0.031 | Beta 1 adrenoreceptor agonist | |||
| 0.064 | 0.041 | 0.064 | NMDA receptor agonist | |||
| 0.029 | 0.006 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 CID_154699628 | ||
| 0.042 | 0.019 | 0.042 | Delayed rectifier potassium channel blocker | |||
| 0.044 | 0.021 | 0.044 | Membrane dipeptidase inhibitor | |||
| 0.032 | 0.01 | 0.032 | Thyroid hormone agonist | |||
| 0.132 | 0.11 | 0.132 | Mcl-1 antagonist | |||
| 0.032 | 0.01 | 0.032 | Hedgehog signaling activator | |||
| 0.027 | 0.005 | 0.027 | Retinoid X beta receptor antagonist | |||
| 0.046 | 0.024 | 0.046 | Kainate receptor antagonist | |||
| 0.062 | 0.041 | 0.062 | TRPA1 antagonist | |||
| 0.042 | 0.021 | 0.067 | Arginase inhibitor | 0.067 0.008 CID_154699628 | CID_154699628 | |
| 0.044 | 0.025 | 0.044 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.028 | 0.008 | 0.028 | Retinoic acid gamma receptor agonist | |||
| 0.035 | 0.016 | 0.035 | Prostaglandin D2 agonist | |||
| 0.039 | 0.02 | 0.039 | Calcitonin receptor agonist | |||
| 0.058 | 0.04 | 0.058 | Dopamine uptake inhibitor | |||
| 0.05 | 0.031 | 0.05 | Dopamine beta hydroxylase inhibitor | |||
| 0.055 | 0.037 | 0.055 | GABA receptor antagonist | |||
| 0.037 | 0.019 | 0.037 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.101 | 0.083 | 0.101 | Calcium channel (voltage-sensitive) blocker | |||
| 0.059 | 0.041 | 0.059 | Heat shock protein 90 beta antagonist | |||
| 0.099 | 0.081 | 0.124 | Multidrug resistance-associated protein 1 inhibitor | 0.124 0.044 CID_154699628 | CID_154699628 | |
| 0.038 | 0.021 | 0.038 | Phosphoglycerate kinase inhibitor | |||
| 0.029 | 0.012 | 0.029 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.026 | 0.01 | 0.026 | 5-Alpha-reductase 2 inhibitor | |||
| 0.089 | 0.072 | 0.089 | Toll-Like receptor 3 antagonist | |||
| 0.045 | 0.029 | 0.045 | Sphingosine 1-phosphate receptor agonist | |||
| 0.271 | 0.255 | 0.271 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.021 | 0.005 | 0.021 | Angiotensin AT1B receptor antagonist | |||
| 0.026 | 0.011 | 0.026 | Leukotriene B4 receptor 2 antagonist | 0.026 0.011 CID_154699628 | ||
| 0.073 | 0.058 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.043 | 0.028 | 0.043 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.036 | 0.022 | 0.036 | Fumarate hydratase inhibitor | |||
| 0.035 | 0.021 | 0.035 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.085 | 0.071 | 0.085 | MAO B inhibitor | |||
| 0.073 | 0.059 | 0.167 | Topoisomerase II alpha inhibitor | 0.167 0.02 CID_154699628 | CID_154699628 | |
| 0.021 | 0.008 | 0.021 | Nicotinic acid receptor 1 antagonist | |||
| 0.025 | 0.012 | 0.025 | Glutamate (mGluR1a) agonist | |||
| 0.113 | 0.101 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.022 | 0.01 | 0.022 | 5-Alpha-reductase 1 inhibitor | |||
| 0.052 | 0.04 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.023 | 0.011 | 0.023 | Retinoic acid alpha receptor antagonist | |||
| 0.02 | 0.009 | 0.02 | Prostaglandin EP4 agonist | |||
| 0.025 | 0.014 | 0.025 | Angiotensin AT2 receptor antagonist | |||
| 0.021 | 0.01 | 0.021 | Retinoic acid receptor antagonist | |||
| 0.018 | 0.008 | 0.018 | Vitamin D receptor agonist | 0.017 0.01 CID_154699628 | ||
| 0.054 | 0.043 | 0.054 | Immunoglobulin Fc receptor antagonist | |||
| 0.065 | 0.056 | 0.065 | Exportin-1 inhibitor | |||
| 0.124 | 0.115 | 0.124 | Growth hormone agonist | |||
| 0.029 | 0.019 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 CID_154699628 | CID_154699628 | |
| 0.019 | 0.01 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.078 | 0.068 | 0.078 | Thioredoxin reductase inhibitor | |||
| 0.065 | 0.056 | 0.065 | MDM2 inhibitor | |||
| 0.033 | 0.024 | 0.033 | Protein kinase C beta I inhibitor | |||
| 0.068 | 0.059 | 0.068 | Phospholipase D inhibitor | |||
| 0.027 | 0.018 | 0.027 | Retinoid X gamma receptor antagonist | |||
| 0.031 | 0.022 | 0.031 | Cholesterol ester transfer protein antagonist | |||
| 0.05 | 0.041 | 0.05 | GABA A receptor antagonist | |||
| 0.044 | 0.036 | 0.044 | Antimetabolite | |||
| 0.089 | 0.08 | 0.229 | Topoisomerase I inhibitor | 0.229 0.02 CID_154699628 | CID_154699628 | |
| 0.069 | 0.061 | 0.069 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.017 | 0.009 | 0.017 | Thyroid hormone alpha antagonist | |||
| 0.099 | 0.092 | 0.099 | MAO inhibitor | |||
| 0.031 | 0.024 | 0.031 | Estrogen-related receptor alpha antagonist | |||
| 0.052 | 0.045 | 0.069 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.069 0.026 CID_154699628 | CID_154699628 | |
| 0.189 | 0.182 | 0.189 | Thioredoxin glutathione reductase inhibitor | |||
| 0.022 | 0.015 | 0.022 | Angiotensin AT1A receptor antagonist | |||
| 0.028 | 0.022 | 0.028 | Liver X receptor alpha antagonist | |||
| 0.034 | 0.029 | 0.034 | Leukotriene A4 hydrolase inhibitor | |||
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.02 | 0.014 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.057 | 0.052 | 0.057 | Prostaglandin F2 alpha antagonist | |||
| 0.031 | 0.026 | 0.031 | Catechol O-methyltransferase inhibitor | |||
| 0.012 | 0.007 | 0.012 | Beta 3 adrenoreceptor agonist | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor agonist | |||
| 0.022 | 0.017 | 0.022 | Retinoid X gamma receptor agonist | |||
| 0.013 | 0.008 | 0.013 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.029 | 0.024 | 0.062 | Squalene synthetase inhibitor | 0.062 0.011 CID_154699628 | CID_154699628 | |
| 0.019 | 0.015 | 0.019 | Caspase 8 inhibitor | |||
| 0.031 | 0.027 | 0.031 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.024 | 0.019 | 0.024 | Prostaglandin H2 antagonist | |||
| 0.025 | 0.02 | 0.116 | Sodium/glucose cotransporter inhibitor | 0.116 0.002 CID_154699628 | CID_154699628 | |
| 0.055 | 0.051 | 0.055 | Carbonic anhydrase inhibitor | |||
| 0.018 | 0.015 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.003 CID_154699628 | CID_154699628 | |
| 0.01 | 0.008 | 0.01 | Thromboxane agonist | |||
| 0.024 | 0.022 | 0.117 | Sodium/glucose cotransporter 2 inhibitor | 0.117 0.002 CID_154699628 | CID_154699628 | |
| 0.023 | 0.021 | 0.023 | Leukotriene D4 antagonist | |||
| 0.08 | 0.079 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 CID_154699628 | CID_154699628 | |
| 0.233 | 0.232 | 0.768 | Cyclophilin D inhibitor | 0.768 0.009 CID_154699628 | CID_154699628 | |
| 0.055 | 0.054 | 0.055 | Phosphodiesterase 1A inhibitor | |||
| 0.023 | 0.022 | 0.023 | Prostaglandin EP4 antagonist | |||
| 0.015 | 0.017 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_154699628 | CID_154699628 | |
| 0.046 | 0.047 | 0.053 | Factor III inhibitor | 0.053 0.027 CID_154699628 | CID_154699628 | |
| 0.046 | 0.049 | 0.097 | Glucose-6-phosphate translocase inhibitor | 0.097 0.007 CID_154699628 | CID_154699628 | |
| 0.04 | 0.046 | 0.083 | Carbonic anhydrase XII inhibitor | 0.083 0.024 CID_154699628 | CID_154699628 | |
| 0.035 | 0.043 | 0.117 | Phosphorylase inhibitor | 0.117 0.01 CID_154699628 | CID_154699628 | |
| 0.088 | 0.099 | 0.217 | Topoisomerase II inhibitor | 0.217 0.03 CID_154699628 | CID_154699628 | |
| 0.103 | 0.118 | 0.197 | DNA repair enzyme inhibitor | 0.197 0.009 CID_154699628 | CID_154699628 | |
| 0.036 | 0.051 | 0.054 | Microtubule stabilization | 0.054 0.023 CID_154699628 | CID_154699628 | |
| 0.014 | 0.032 | 0.021 | Corticosteroid-like | 0.021 0.015 CID_154699628 | CID_154699628 | |
| 0.036 | 0.058 | 0.069 | Aldose reductase inhibitor | 0.069 0.028 CID_154699628 | CID_154699628 | |
| 0.021 | 0.046 | 0.037 | Toll-Like receptor 4 agonist | 0.037 0.005 CID_154699628 | CID_154699628 | |
| 0.006 | 0.038 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CID_154699628 | CID_154699628 | |
| 0.168 | 0.206 | 0.516 | Immunomodulator | 0.516 0.021 CID_154699628 | CID_154699628 | |
| 0.135 | 0.179 | 0.431 | Tumour necrosis factor alpha release inhibitor | 0.431 0.022 CID_154699628 | CID_154699628 | |
| 0.048 | 0.097 | 0.098 | Histone deacetylase stimulant | 0.098 0.029 CID_154699628 | CID_154699628 | |
| 0.048 | 0.097 | 0.098 | Histone deacetylase SIRT1 stimulant | 0.098 0.029 CID_154699628 | CID_154699628 | |
| 0.043 | 0.093 | 0.201 | Antineoplastic antibiotic | 0.201 0.021 CID_154699628 | CID_154699628 | |
| 0.023 | 0.084 | 0.079 | Antibiotic Aminoglycoside-like | 0.079 0.004 CID_154699628 | CID_154699628 | |
| 0.011 | 0.076 | 0.022 | Dopamine D1 agonist | 0.022 0.017 CID_154699628 | CID_154699628 | |
| 0.08 | 0.152 | 0.295 | Cell adhesion inhibitor | 0.295 0.01 CID_154699628 | CID_154699628 | |
| 0.002 | 0.076 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_154699628 | CID_154699628 | |
| 0.012 | 0.094 | 0.058 | Protein 30S ribosomal subunit inhibitor | 0.058 0.007 CID_154699628 | CID_154699628 | |
| 0.049 | 0.163 | 0.153 | Cell adhesion molecule inhibitor | 0.153 0.014 CID_154699628 | CID_154699628 | |
| 0.021 | 0.14 | 0.105 | Protein 50S ribosomal subunit inhibitor | 0.105 0.012 CID_154699628 | CID_154699628 | |
| 0.007 | 0.133 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 CID_154699628 | CID_154699628 | |
| 0.105 | 0.233 | 0.141 | CC chemokine 6 receptor antagonist | 0.141 0.038 CID_154699628 | CID_154699628 | |
| 0.042 | 0.21 | 0.118 | DNA intercalator | 0.118 0.059 CID_154699628 | CID_154699628 | |
| 0.038 | 0.295 | 0.08 | Falcipain inhibitor | 0.08 0.074 CID_154699628 | CID_154699628 | |
| 0.037 | 0.3 | 0.077 | Falcipain 2 inhibitor | 0.077 0.074 CID_154699628 | CID_154699628 | |
| 0.047 | 0.312 | 0.238 | Anticoagulant | 0.238 0.041 CID_154699628 | CID_154699628 | |
| 0.02 | 0.333 | 0.08 | Factor IXa inhibitor | 0.08 0.016 CID_154699628 | CID_154699628 | |
| 0.046 | 0.367 | 0.085 | T cell inhibitor | 0.085 0.049 CID_154699628 | CID_154699628 | |
| 0.005 | 0.364 | 0.021 | Motilin receptor agonist | 0.021 0.019 CID_154699628 | CID_154699628 | |
| 0.034 | 0.587 | 0.188 | Angiogenesis inhibitor | 0.188 0.184 CID_154699628 | CID_154699628 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |